Skip to content
Stop using now Drug recall · FDA · Published May 13, 2015

West-Ward Fentanyl Citrate Recall: Impurity Risk

West-Ward recalls Fentanyl Citrate Inj. due to failed impurity specifications. Check lot numbers and expiration dates for affected vials.

🇺🇸 FDA recall #D-1139-2015DrugWest-Ward ›
Take action

Contact the company

Recalling firmWest-Ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Fentanyl Citrate Injection, USP, CII because the product failed impurity and degradation specifications during stability testing. The recall affects specific lots distributed nationwide in cartons of 25 single-dose vials. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/44708-west-ward-pharmaceutical-corp-recalls-fentanyl-citrate-inj-usp-cii.

Source Summary by GovInfoNow · govinfonow.com/recall/44708-west-ward-pharmaceutical-corp-recalls-fentanyl-citrate-inj-usp-cii · Updated October 12, 2026 · FDA enforcement record: FDA #D-1139-2015

Cite this page

“West-Ward Fentanyl Citrate Recall: Impurity Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44708-west-ward-pharmaceutical-corp-recalls-fentanyl-citrate-inj-usp-cii. Based on FDA recall #D-1139-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1139-2015%22&limit=1).

The FDA announced on May 13, 2015, that West-Ward Pharmaceutical Corp. voluntarily recalled Fentanyl Citrate Injection due to failed impurity and degradation specifications. The recall affects 14,649 cartons distributed nationwide.

How to tell if you have it

  • Brand: West-Ward
  • Product: Fentanyl Citrate Injection
  • NDC: 0641-6028-25
  • Lot codes: 043410, 053391, 073340, 083330, 083333, 083335, 093319, 093321, 093323, 103316, 103318
  • Expiration dates: April 2015 through October 2015

The hazard

The recall was initiated because the product failed impurity and degradation specifications during 12-month stability testing. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Previous recalls include a VersaPharm Ethambutol recall on October 2, 2014, for subpotency risk, and a West-Ward Isoniazid recall on May 20, 2014, for failed dissolution specifications. Other recent recalls of similar products include Wells Pharma Fentanyl Citrate Solution Recall (April 1, 2026), Wells Pharma Fentanyl Citrate Injectable Solution Recall (April 1, 2026), and Wells Pharma Fentanyl Citrate Recall (April 1, 2026).

How to tell if you have this one

Look for Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL), manufactured by West-Ward in Eatontown, NJ. Affected lots include: 043410 (Exp 04/2015), 053391 (Exp 05/2015), 073340 (Exp 07/2015), 083330, 083333, 083335 (Exp 08/2015), 093319, 093321, 093323 (Exp 09/2015), and 103316, 103318 (Exp 10/2015). The NDC is 0641-6028-25.

  • Brand
    West-Ward
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your inventory matches the affected lot numbers listed in the recall record.

  2. Stop Distribution

    Do not distribute or administer any vials from the recalled lots to patients.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: May 13, 201512. FDA classified it Class III: Jun 16, 201523. Published in FDA’s Enforcement Report: Jun 24, 201534. FDA terminated the recall: Apr 6, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1139-2015 (May 13, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1139-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA